Ebola booster vaccine starts first trials in Oxford
By Ben Hirschler LONDON (Reuters) - Scientists at Oxford University have launched the first clinical tests of a new Ebola vaccine ap...
Read More »By Ben Hirschler LONDON (Reuters) - Scientists at Oxford University have launched the first clinical tests of a new Ebola vaccine ap...
Read More »MOSCOW (Reuters) - Russia's Veterinary and Phytosanitary Surveillance Service (VPSS) said on Thursday it was implementing temporary ...
Read More »SEOUL (Reuters) - South Korea has confirmed a fresh case of foot-and-mouth disease at a hog farm, the agriculture ministry said in a...
Read More »(Reuters) - The trustee overseeing the bankruptcy of a Massachusetts pharmacy linked to a 2012 meningitis outbreak that killed 64 pe...
Read More »By Julie Steenhuysen CHICAGO (Reuters) - A sampling of flu cases so far this season suggests the current flu vaccine may not be a go...
Read More »NEW YORK (Reuters) - A U.S. healthcare worker who had been in West Africa and may have been exposed to the Ebola virus is being tran...
Read More »By Jonathan Stempel (Reuters) - Herbalife Ltd won preliminary court approval of its $15 million settlement of class-action litigatio...
Read More »By Lisa Maria Garza DALLAS (Reuters) - The city of Dallas said on Wednesday it spent more than $155,000 on the emergency response to...
Read More »(Reuters) - The second week of open enrollment in 2015 health insurance plans offered under President Barack Obama's healthcare refo...
Read More »By Kathryn Doyle (Reuters Health) - Where advanced cancer patients live affects the likelihood that they can enroll in a treatment c...
Read More »